Mandalà, Mario

Cutaneous toxicities of BRAF inhibitors: clinical and pathological challenges and call to action. [electronic resource] - Critical reviews in oncology/hematology Nov 2013 - 318-37 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

1879-0461

10.1016/j.critrevonc.2013.06.002 doi


Antineoplastic Agents--adverse effects
Carcinoma, Squamous Cell--chemically induced
Humans
Melanoma--complications
Protein Kinase Inhibitors--adverse effects
Proto-Oncogene Proteins B-raf--antagonists & inhibitors
Research
Skin--drug effects
Skin Diseases--chemically induced